Literature DB >> 2424541

Interfering with the real cold.

G Scott.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2424541      PMCID： PMC1340425          DOI： 10.1136/bmj.292.6533.1413

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  10 in total

1.  Rhinovirus transmission: one if by air, two if by hand.

Authors:  J M Gwaltney; J O Hendley
Journal:  Am J Epidemiol       Date:  1978-05       Impact factor: 4.897

Review 2.  Rhinovirus colds.

Authors:  R J Phillpotts; D A Tyrrell
Journal:  Br Med Bull       Date:  1985-10       Impact factor: 4.291

3.  Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2.

Authors:  F G Hayden; S E Mills; M E Johns
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

4.  Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.

Authors:  P G Higgins; R J Phillpotts; G M Scott; J Wallace; L L Bernhardt; D A Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.

Authors:  R M Douglas; B W Moore; H B Miles; L M Davies; N M Graham; P Ryan; D A Worswick; J K Albrecht
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

6.  Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.

Authors:  R J Phillpotts; P G Higgins; J S Willman; D A Tyrrell; D S Freestone; W M Shepherd
Journal:  J Interferon Res       Date:  1984

7.  Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.

Authors:  R M Douglas; J K Albrecht; H B Miles; B W Moore; R Read; D A Worswick; A J Woodward
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

8.  Tolerance of one-month intranasal interferon.

Authors:  G M Scott; J K Onwubalili; J A Robinson; C Doré; D S Secher; K Cantell
Journal:  J Med Virol       Date:  1985-10       Impact factor: 2.327

9.  An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2.

Authors:  R J Phillpotts; G M Scott; P G Higgins; J Wallace; D A Tyrrell; C L Gauci
Journal:  Antiviral Res       Date:  1983-08       Impact factor: 5.970

10.  Isolation of rhinoviruses and coronaviruses from 38 colds in adults.

Authors:  H E Larson; S E Reed; D A Tyrrell
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.